Lightbody, Elizabeth D.
Sklavenitis-Pistofidis, Romanos
Wu, Ting
Tsuji, Junko
Firer, Danielle T.
Agius, Michael P. https://orcid.org/0000-0003-2356-4274
Dutta, Ankit K. https://orcid.org/0000-0003-2535-3729
Barr, Hadley https://orcid.org/0000-0003-0595-5984
Kim, Sungjae
Alberge, Jean-Baptiste https://orcid.org/0000-0002-4218-7294
Nersesian, Sarah
Coorens, Tim https://orcid.org/0000-0002-5826-3554
Haradhvala, Nicholas J. https://orcid.org/0000-0003-1113-3135
Su, Nang Kham
Boehner, Cody J.
Aranha, Michelle P. https://orcid.org/0000-0002-8230-5726
Rahmat, Mahshid
Konishi, Yoshinobu https://orcid.org/0000-0003-1212-7212
Hevenor, Laura
Towle, Katherine
Horowitz, Erica
Perry, Jacqueline
Davis, Maya
Walsh, Kelly A.
Cea-Curry, Christian J.
Fleming, Grace
Vinyard, Michael E.
Heilpern-Mallory, Daniel https://orcid.org/0000-0003-4296-015X
El-Khoury, Habib
Cowan, Annie
Ready, John E.
Marinac, Catherine R.
Getz, Gad https://orcid.org/0000-0002-0936-0753
Ghobrial, Irene M. https://orcid.org/0000-0001-7361-3092
Article History
Received: 7 September 2024
Accepted: 23 May 2025
First Online: 8 August 2025
Competing interests
: J.T., D.T.F., T.W., M.P. Agius, A.K.D., H.B., S.K., J.-B.A., T.C., S.N., N.K.S., C.J.B., M.P. Aranha, M.R., Y.K., L.H., K.T., E.H., J.P., M.D., K.A.W., C.J.C.-C., G.F., M.E.V., D.H.-M., H.E.-K., A.C., J.E.R. and C.R.M. declare no competing interests. R.S.-P. is a co-founder, equity holder and consultant for PreDICTA Biosciences, a precision oncology company integrating multiomics and liquid biopsies to develop diagnostic and therapeutic products. N.J.H. is a consultant for Constellation Pharmaceuticals. G.G. is an inventor on patent applications filed by the Broad Institute related to MSMuTect, MSMutSig, POLYSOLVER, SignatureAnalyzer-GPU, MSIDetect and MinumuMM-seq. G.G. receives research funds from IBM, Pharmacyclics and Ultima Genomics, and is a founder of, consultant for and holds privately held equity in Scorpion Therapeutics; he is also a founder of and holds privately held equity in PreDICTA Biosciences. I.M.G. has a consulting or advisory role with AbbVie, Adaptive, Amgen, Aptitude Health, Bristol Myers Squibb, GlaxoSmithKline, Huron Consulting, Janssen, Menarini Silicon Biosystems, Oncopeptides, Pfizer, Sanofi, Sognef, Takeda, The Binding Site and Window Therapeutics; has received speaker fees from Vor Biopharma and Veeva Systems, Inc.; is a co-founder, equity holder and consultant for PreDICTA Biosciences; and her spouse is the CMO and equity holder of Disc Medicine. E.D.L., R.S.-P., G.G. and I.M.G. have submitted a patent application related to this work.